Psoriasiform-lichenoid-like dermatosis in three dogs treated with microemulsified cyclosporine A

Journal of the American Veterinary Medical Association

Volumn 223, Issue 7, 2003, Pages 1013-1016+986

  Werner, Alexander H ^a  

^a Veterinary Specialty Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; CEFALEXIN; CLINDAMYCIN; CORTICOSTEROID; CYCLOSPORIN A; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; NICOTINAMIDE; PREDNISONE;

ANIMAL MODEL; ARTICLE; DERMATITIS; DOG; IMMUNOSUPPRESSIVE TREATMENT; LICHENOID ERUPTION; MALE; MICROEMULSION; NONHUMAN; PRURITUS; PSORIASIS; SKIN DISEASE; SKIN TOXICITY; TREATMENT OUTCOME; VETERINARY MEDICINE;

ANIMALS; CYCLOSPORINE; DERMATITIS, SEBORRHEIC; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; LICHEN PLANUS; MALE; PSORIASIS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0141540534     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2003.223.1013     Document Type: Article

References (12)

1. White SD. Nonsteroidal immunosuppressive therapy. In: Bonagura JD, ed. Current veterinary therapy XIII. Philadelphia: WB Saunders Co, 2000;536-538.
2. Mason KV, Robson DC. Clinical pearls of wisdom: practice tips for skin cases. In: Thoday KL, Foil CS, eds. Advances in veterinary dermatology. Vol 4. Oxford, England: Blackwell Science Ltd, 2002;254-266.
3. Fontaine J, Olivry T. Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study. Vet Rec 2001;148:662-663.
4. Olivry T, Rivierre C, Jackson HA, et al. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisone-controlled trial. Vet Dermatol 2002; 13:77-87.
5. Neoral [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corp, 2001.
6. Seibel W, Sundberg JP, Lesko LJ, et al. Cutaneous papillomatous hyperplasia in cyclosporine-A treated beagles. J Invest Dermatol 1989;93:224-230.
7. Scott DW, Miller Jr WH, Griffin CE. Muller and Kirk's small animal dermatology. Philadelphia: WB Saunders Co, 2001;931.
8. Mason KV, Halliwell RE, McDougal BJ. Characterization of lichenoid-psoriasiform dermatosis of Springer Spaniels. J Am Vet Med Assoc 1986;189:897-901.
9. Burrows A, Mason KV. Observations of the pathogenesis and treatment of lichenoid-psoriasiform dermatitis of Springer Spaniels (abstr), in Proceedings. Annu Meet Am Assoc Vet Dermatol/Am Coll Vet Dermatol 1994;10:81.
10. Khandke L, Krane JF, Ashinoff R, et al. Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathways. Arch Dermatol 1991;127: 1172-1179.
11. Kanitakis J, Thivolet J. Cyclosporine: an immunosuppressant affecting epithelial cell proliferation. Arch Dermatol 1990;126: 369-375.
12. Berglundh T, Lindhe J, Tarkowski A. Effects of cyclosporine A on plasma cells in experimental gingivitis in dogs. J Clin Periodontol 1996;23:507-511.